Introduction and Objective: Anxiety, depression, ADHD, and diabetes distress are all associated with adherence issues and risk for poor health outcomes in people with type 1 diabetes (T1D). However, there is limited research assessing youth at time of T1D diagnosis for psychological factors that increase risk for low treatment adherence. Our objective is to assess […]
Read MoreAuthor: sugaradmin
1348-P: Combining 1-Hour Plasma Glucose and Fasting Plasma Glucose to Improve Diabetes Detection in Africans—The Africans in America Study
Introduction and Objective: The International Diabetes Federation suggests replacing the 2-h plasma glucose (PG) ≥200 mg/dL with a 1-h PG ≥209 mg/dL for diagnosing type 2 diabetes (T2D). However, in the Africans in America cohort, the sensitivity of the 1-h PG ≥209 mg/dL threshold was only 67%. Additionally, fasting plasma glucose (FPG) >126 mg/dL alone […]
Read More137-OR: Towards Retrievable, Immune-Priviledged, 3D-Printed Hydrogels to Deliver Functional Islets
Introduction and Objective: Transplantation of free islets is limited by the need for systemic immune suppression. To protect transplanted cells from the autoimmune response and avoid the negative effects of systemic immune suppression, which can include damage to remaining and transplanted beta cells, we are developing physical immune-protective hydrogels. We demonstrated good survival and function […]
Read More1347-P: Glycated Hemoglobin (A1C) Testing—Ineffectiveness Due to Hematological Alterations
Introduction and Objective: Glycated hemoglobin (A1C) is widely used in the screening and follow-up of patients with diabetes mellitus (DM), making its accuracy critical for patient care. However, A1C results can be influenced by various factors, including alterations in blood cell counts. This study aimed to evaluate the correlation between hematological abnormalities and inaccuracies in […]
Read More36-PUB: Developing an Evidence-Based Care Pathway for Transgender Youth with Obesity—Integration of Patient and Caregiver Perspectives
Introduction and Objective: Pediatric obesity rates continue to rise, and with them, comorbidities such as Type 2 diabetes. Transgender youth may be more susceptible to these conditions due to gender- and weight-based stigmatization, increased BMI from gender-affirming therapies, and maladaptive weight management behaviors. Furthermore, current pediatric weight management uses a “one size fits all” approach […]
Read More1288-P: Waist–to–Body-Mass-Index Ratio Predicts Cardiovascular Events in Patients with Coronary Artery Disease beyond the Metabolic Syndrome
Introduction and Objective: The waist circumference-to-body-mass-ratio (W/BMI-Ratio) has attracted interest as a predictor of cardiovascular risk. Its power to predict cardiovascular events in patients with established coronary artery disease (CAD) is not known and is addressed in the present study.Methods: We prospectively recorded cardiovascular events in 1329 patients with angiographically verified coronary artery disease. The […]
Read More259-OR: Evaluating Diabetic Foot Ulcer Recognition Algorithms for Patients of Color
Introduction and Objective: Computer vision offers an opportunity to automatically analyze foot images to segment diabetic foot ulcers (DFU) and determine clinically relevant characteristics. Although diabetic foot complications take a disproportionate toll on communities of color, these communities are underrepresented in dermatologic image datasets, which may propagate health disparities. Are current state-of-the-art foot ulcer recognition […]
Read More1287-P: Type 2 Diabetes and Albuminuria as Predictors of Major Cardiovascular Events in Patients with Established Cardiovascular Disease
Introduction and Objective: This study aims to investigate the single and joint effects of T2DM and albuminuria on major cardiovascular events (MACE) in patients with established cardiovascular disease (CVD).Methods: We prospectively investigated 854 patients with CVD (743 with coronary artery disease and 111 with peripheral artery disease) over 9.3±4.5 years. Albuminuria was defined as urine […]
Read More2135-LB: The Study of Abnormal SLAMF Molecular Expression on Immune Cells in Type 1 Diabetic Patients and Associated Mechanism
Introduction and Objective: At present, the pathogenesis of T1DM is not completely clear, and more and more studies have shown that CD8+T cells play an important role in the pathogenesis of type 1 diabetes. It has been reported that the signaling lymphocyte activated molecular family (SLAMF) is abnormally expressed in various immune disorders and affects […]
Read More1286-P: The Visceral Adiposity Index Predicts the Development of Type 2 Diabetes Mellitus in Patients with Established Coronary Artery Disease
Introduction and Objective: The visceral adiposity Index (VAI) is a reliable biomarker of insulin resistance and is associated with the metabolic syndrome as well as with type 2 diabetes (T2DM). Its power to predict the development of T2DM in patients with established coronary artery disease (CAD) is unclear and is addressed in the presence study.Methods: […]
Read More